Department of Pharmacology and Moores Cancer Center, School of Medicine, University of California at San Diego, La Jolla, California 92093, USA.
Nat Cell Biol. 2012 Dec;14(12):1322-9. doi: 10.1038/ncb2615.
Organ development is a complex process governed by the interplay of several signalling pathways that have critical functions in the regulation of cell growth and proliferation. Over the past years, the Hippo pathway has emerged as a key regulator of organ size. Perturbation of this pathway has been shown to play important roles in tumorigenesis. YAP, the main downstream target of the mammalian Hippo pathway, promotes organ growth, yet the underlying molecular mechanism of this regulation remains unclear. Here we provide evidence that YAP activates the mammalian target of rapamycin (mTOR), a major regulator of cell growth. We have identified the tumour suppressor PTEN, an upstream negative regulator of mTOR, as a critical mediator of YAP in mTOR regulation. We demonstrate that YAP downregulates PTEN by inducing miR-29 to inhibit PTEN translation. Last, we show that PI(3)K–mTOR is a pathway modulated by YAP to regulate cell size, tissue growth and hyperplasia. Our studies reveal a functional link between Hippo and PI(3)K–mTOR, providing a molecular basis for the coordination of these two pathways in organ size regulation.
器官发育是一个复杂的过程,受几种信号通路的相互作用调控,这些信号通路在细胞生长和增殖的调节中具有关键功能。在过去的几年中,Hippo 通路已成为调节器官大小的关键调节剂。该通路的扰动已被证明在肿瘤发生中发挥重要作用。Hippo 通路的主要下游靶标 YAP 促进器官生长,但这种调节的潜在分子机制尚不清楚。在这里,我们提供了证据表明 YAP 激活了哺乳动物雷帕霉素靶蛋白(mTOR),mTOR 是细胞生长的主要调节剂。我们已经确定肿瘤抑制因子 PTEN 是 mTOR 的上游负调节剂,是 YAP 在 mTOR 调节中的关键介质。我们证明 YAP 通过诱导 miR-29 抑制 PTEN 翻译来下调 PTEN。最后,我们表明 PI(3)K–mTOR 是 YAP 调节的途径,用于调节细胞大小、组织生长和增生。我们的研究揭示了 Hippo 和 PI(3)K–mTOR 之间的功能联系,为这两个途径在器官大小调节中的协调提供了分子基础。